MDM2 and breast cancer: Using the dual-luciferase reporter assay, we showed that the luciferase activity of the wild-type, rather than the mutant, MDM2-3′ UTR reporter was significantly decreased in BC cells transfected with miR-16-1-3p mimics (Figure 6C).